Advertisement

Topics

Optovue Incorporated Company Profile

11:07 EDT 19th September 2017 | BioPortfolio

Optovue Incorporated is a privately-held ophthalmic device company dedicated to working with eye care professionals and clinical researchers to lead the commercialization of new imaging modalities that improve diagnosis and therapy of ocular disease. Optovue has achieved widespread market success through a combination of unique data analysis design, a reputation for excellent customer service, and rapid innovation of its technology in response to physician feedback. The company is headquartered in Fremont, CA, with operations in Carlsbad, CA and European operations in Heidelberg, Germany.


News Articles [9 Associated News Articles listed on BioPortfolio]

FDA clears Optovue’s epi-mapping software

Optovue’s epithelial thickness mapping software has become the first to be cleared by the FDA for quantitative measurements of the epithelial and stromal layers of the cornea, according to a company...

Optovue, Inc. Unveils New Angiovue Essential OCTA At

  Life Sciences Jobs   ...

Optovue, Inc. First In U.S. To Receive FDA Clearance For Corneal Epithelial Thickness Mapping

  Life Sciences Jobs   ...

Optovue, Inc. Wins FDA???s First Clearance for Corneal Epithelial Thickness Mapping

  Life Sciences Jobs   ...

Optovue Unveils New AngioVue Essential OCTA at the International Vision Expo

Company Continues to Advance Diagnostic Capabilities Across Practice Settings Optovue, the global leader in the development of optical coherence tomography (OCT) ...

Optovue First in US to Receive FDA Clearance for Corneal Epithelial Thickness Mapping

New Mapping Technique May be Early Indicator of Ocular Health Optovue announced today that the U.S. Food and Drug Administration (FDA) has cleared the company’s epith...

Corcept Therapeutics Announces Presentations on Mifepristone for the Treatment of Patients with Hypercortisolism at the American Association of Clinical Endocrinologists 26th Annual Congress

MENLO PARK, CA -- (Marketwired) -- 05/04/17 -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery, development and commercialization of drugs that tre...

Milestone Scientific Announces Children's Hospital of Pittsburgh to use The Wand(R) Computer Assisted Anesthesia System for Pediatric Patients

LIVINGSTON, NJ --(Marketwired - September 14, 2017) - Milestone Scientific Inc. (NYSE American: MLSS) (NYSE MKT: MLSS), a medical company that develops and commercializes a growing portfolio of propri...

PubMed Articles [5 Associated PubMed Articles listed on BioPortfolio]

An automated framework to quantify areas of regional ischemia in retinal vascular diseases with OCT angiography.

In this observational and cross-sectional study, capillary non perfusion (CNP) and vascular changes in branch retinal vein occlusion (BRVO, sample size (n) = 26) and choroidal neovascularization (...

AERODYNAMIC PROPERTIES AND IN SILICO DEPOSITION OF MELOXICAM POTASSIUM INCORPORATED IN A CARRIER-FREE DPI PULMONARY SYSTEM.

Dry powder inhalers (DPIs) have been among the fastest developing inhaler forms in the past decades. Researches are focusing on the formulation of carrier-free powders to obtain a higher deep-lung dep...

OCT layered tomography of the cornea provides new insights on remodeling after photorefractive keratectomy.

OCT topography of corneal layers was generated to analyze the remodeling of the epithelium and stroma after photorefractive keratectomy (PRK). Myopic PRK was performed in 15 patients. One eye underwen...

Aqueous humor endothelin-1 and total retinal blood flow in patients with non-proliferative diabetic retinopathy.

PurposeThe purpose of this study was to determine the association between aqueous ET-1 levels and total retinal blood flow (TRBF) in patients with non-insulin-dependent type 2 diabetes mellitus (T2DM)...

Angio-OCT de la zona avascular foveal en ojos con oclusión venosa de la retina.

Objetivo: El objetivo del estudio comprendía visualizar y cuantificar las alteraciones patológicas de la zona avascular foveal (ZAF) mediante angio-OCT en ojos con oclusión venosa de la retina (OVR...

Clinical Trials [5 Associated Clinical Trials listed on BioPortfolio]

Corneal and Anterior Segment Optical Coherence Tomography - Optovue

The objective of the study is to further develop clinical applications for the high speed corneal and anterior segment optical coherence tomography (CAS-OCT) system developed by Optovue, I...

Reliability of Pachymetry Measurement With FD-oCT, ORA, Confoscan 4 and Ultrasound

The purpose of this study is to assess the repeatability, reproducibility, and agreement of central corneal thickness measured by Fourier Domain Optical Coherence tomography (FD-OCT, OptoV...

Evaluation of RTVue XR With SSADA

Optovue has implemented a motion contrast imaging software in RTVue XR, a split spectrum amplitude decorrelation algorithm (SSADA), for non-invasive imaging of ocular vasculature. Consente...

SD-OCT Angiography

The objective of this study is to image retinal vascular alterations in patients with retinal disease using the AngioVue OCT-A system and understand the information these images provide. T...

The IAI-OCTA Study; a Study of OCT-Angiography Analysis Efficacy

A study investigating the ability of OCTA imaging technology to identify and analyze untreated type 1, 2, and 3 neovascular membrane lesions in treatment naive patients with exudative macu...

Companies [38 Associated Companies listed on BioPortfolio]

Optovue, Inc.

Optovue, Inc. is a privately held medical device company founded in 2003. Headquartered in Fremont, Calif., the company is dedicated to the advancement and commercializatio...

Optovue Incorporated

Optovue Incorporated is a privately-held ophthalmic device company dedicated to working with eye care professionals and clinical researchers to lead the commercialization of new imaging modalities tha...

PRAECIS PHARMACEUTICALS INCORPORATED

PRAECIS PHARMACEUTICALS INCORPORATED is a biopharmaceutical company focused on the discovery and development of novel compounds to address unmet medical needs or improve existing therapies.PRAECIS has...

Optovue Inc.

RTVue was the first FDA cleared Fourier domain (also known as spectral domain) OCT launched in the United States, and also the first OCT cleared by the U.S. Food and Drug Administration for both corne...

Pharmapraxis

Founded in 2008 by the Axis Biotec Brasil™ group (www.axisbiotec.com.br), PharmaPraxis has incorporated technologies, and will develop and launch biologic products in Brazil....

More Information about "Optovue Incorporated" on BioPortfolio

We have published hundreds of Optovue Incorporated news stories on BioPortfolio along with dozens of Optovue Incorporated Clinical Trials and PubMed Articles about Optovue Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Optovue Incorporated Companies in our database. You can also find out about relevant Optovue Incorporated Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record